Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 26, 2012

Cast Your Vote Now for The Latest and Greatest in Biotech!

Cast Your Vote Now for The Latest and Greatest in Biotech!

The best thing in biotech this year was... you tell us! [© Elena Marynina - Fotolia.com]

  • GEN is taking a survey and we want you, practicing biotech researchers, engineers, and technicians, to tell us what you consider “THE” single, most important life science tool or technology that was introduced in 2012. We’re asking you because you are in the best position to know. All major life science specialties, e.g., drug discovery, R&D, and bioprocessing, are fair game for the survey.

    So, in your opinion, what was the most significant life science tool or technology to make its debut this year? Click here to take the survey.

    The survey closes on Oct 31, 2012 and the listing of the GEN Ten Top Life Science Tools and Technologies for 2012 will appear in the January 1, 2013 issue of GEN, and on our website on January 2, 2013. The choice of the final GEN Ten Tools and Technologies will be made by members of GEN’s Advisory Boards, based largely on the uniqueness and utility of the nominated technologies and by the descriptions provided by you, the submitting scientists, researchers, and technicians.

    We welcome your nominations for the GEN Ten Top Life Science Tools and Technologies for 2012 and we look forward to hearing from you!



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »